Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 April 2022 | Story Lunga Luthuli | Photo Supplied
Lizandré Mulder
Lizandré Mulder, University of the Free State LLB graduate, does not believe in having a role model, but in striving to be a better version of herself.

Moving from Jansenville – a town outside Uitenhage – to Bloemfontein for her LLB studies, things got off to a shaky start for Lizandré Mulder. New in a ‘big town’, the ‘country girl’ felt out of her element and not used to big-city life. Thanks to her lecturers, the journey to a legal qualification at the University of the Free State (UFS) ended with an average final-year mark of 80% for the Law graduate.

Back in Jansenville, Lizandré’s neighbour nicknamed her ‘klein prokureurtjie (little lawyer)’ as she was growing up, because she had a ‘habit of arguing’, which motivated her to choose law as a career. She says, “arguing with facts earlier, has turned into a passion”. “The competitive side of me always wants to win; I guess that makes me the perfect candidate for a future advocate,” she says.

Managing undergraduate studies, Lizandré – who is also an accomplished athlete – says all she did was study and train. “The only thing I struggled with was my sleeping schedule, as I was constantly tired from hard training, and I studied till the morning hours while I had to wake up again early for morning training.”

The track, field, and cross-country runner has received numerous national medals for the sport and will unfortunately miss the invitation to the annual Excellence Awards in the Faculty of Law, as she will be competing in this year’s South African Athletics Championships in Cape Town on 22 April 2022.

Graduating with the LLB degree, Lizandré plans to finish her master’s degree with a possible topic on the legality of human gene editing in South Africa for the purposes of disease treatment or the prevention thereof.

Lizandré does not believe in having a role model, but to “always try to better myself in every aspect of life. I always believed that true inspiration and motivation come from within”.

After completing her master’s degree, Lizandré will decide on her future career path. She says: “I am still deciding whether I want to remain in Bloemfontein or relocate to Potchefstroom, as the latter has a law firm specialising in medical negligence, a field I would like to specialise in. Besides this, the two cities also boast the best athletics coaches in DB Prinsloo, Head of KovsieSport, and Jean Verster in Potchefstroom has mentored South African award-winning runner, Caster Semenya.

“Somewhere in the future, I definitely also plan on doing my doctoral degree in Law,” says Lizandré.

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept